SlideShare a Scribd company logo
1 of 13
DRUG USED IN GERIATRICS
BY VRUSHALI NEVE
Asst. professor
Pharmacology dept.
Introduction
1.Geriatrics refers to physical, pathological aspects of elderly
2.The elderly have multiple and often chronic diseases.
3.It is not surprising tharefore that they are major consumer of
drugs.
4.Common diseases in geriatrics are:
A. Hypertension
B. Dibaties mellitus
C. Arthritis
D. Hearing loss
E. Parkinsonims disease
F. Alzheimer disease
PRINCIPLE UNDERLYING FACTORS
• Altered Pharmacokinetics
• Altered Pharmacodynamic
• Multiple drug therapy
• Poor compliance
Pharmacokinetic changes in geriatrics
Ageing result in many physiological changes that could affect
absorption, first pass metabolism ,distribution ,protein binding and
elimination of drugs
Age related changes in GI tract ,liver and kidney are:
1.Reduce gastric acid secretion
2.Decresed GI motility
3.Reduced total surface of absorption
4.Reduced splanchnic blood flow
5.Reduced liver size
6.Reduced liver blood flow
7.Reduced glomerular filtration
8.Reduced renal tubular filtration
1. Absorption: There is delay in gastric emptying, reduction in
gastric acid output with aging. Absorption of some drug like
digoxin may be slower .
2. First pass metabolism: a .After absorption drug are
transported via portal circulation to liver where many lipid
soluble drugs are metabolized extensively.
b. This result in marked reduction in systemic bioavailability.
c. Minor reduction in first pass metabolism can result in
significance increase in bioavailability of such drugs.
3. Distribution: Age related physiological change which may affect
drug distribution are :
1. reduced lean body mass
2.Reduced total body water
3. Increased total body fat
4. Lower serum albumin level
 Increased body fat in eldrly result in increased volume of
distribution for fat soluble compound such as clomethiazole
,diazepam.
 Reduction in body water result in reduced volume of
distribution of water soluble drugs like cimetidine, digoxin,
alcohol
 Plasma albumin level decreases with age therefore free
fraction of acidic drugs like cimetidine, furosemide will
increases
4. Renal clearance: There will be variability in renal function in
elderly , in general glomerular filtration rate decline which affect
renal plasma flow and renal tubular function. Because of marked
variability in renal function in elderly dosage of predominantly
renaly excreted drug should be indiviuialized.
5.Hepatic clearance, ClH: It is depend on hepatic blood flow Q,
and steady state extraction ratio E, as seen in formula :
Cl H = Q × Ca- Cv/Ca
where Ca and Cv are arterial and venous
concentrations of drug
Pharmacodynamics
1.Age related changes in specific receptors and target sites:
1.α adrenoreceptors: It appears to reduced with ageing while α1
adrenoreceptor responsivness is unaffected
2.β adrenoreceptors: Its function is decline with age. It is recognise
that chronotropic response to isoprenaline infusion is less marked
in elderly
2.Reduction in homeostasis:
1. Orthostatic circulatory response: Structural changes in vascular
tree that occur with ageing . Antihypertensive drug with α receptor
blocking effect, antiparkinson drugs more likely to produce
hypotension in elderly
2.Thermoregulation: Increases of thermoregulatory mechanism in
elderly .Ex. Benzodiazepines, opioids, alcohol.
3. Congitive function :Aging is associated with marked structural
and neurochemical changes in CNS
Drugs that need to be used with caution in
elderly
DRUGS SIGNIFICANT ADR SPECIAL
CONSIDERATION
NSAID GI, Ulceration, bleeding
renal impairment
First try Paracetamol,
monitor renal function
Antibiotic- Cotrimazole Serious hypersensitivity
reaction
Trimethoprime is equally
safe, effective for UTI
Sulfonylureas (long
acting)
Increase risk of
hypoglycemia
Shorter acting agents are
preferred
Colchicine Diarrhoea ,dehydration Not recommended for
chronic therapy
Principle and goals of drug therapy
1. Unnecessary use of hypnotics should be avoided in mild
hypertension
2. Aim of treatment is not just to prolong life but also to improve
quality of life
3. Drug history will help to avoid potentially serious drug
interaction
4. Dose titration will help to know age related alteration that may
effect drug response
5. Packaging and labeling: Many elderly patients with arthritis
find it difficult to open container
Care to be taken
 Select drugs reported to be safe
 Avoid unsafe drugs
 Prepare dose and dosing schedule
 Record drug history carefully before prescription
 Try to reduce use of number of drugs
THANK YOU

More Related Content

What's hot

Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reactionSubhash Yende
 
DRUG INFORMATION RESOURCES.pptx
DRUG INFORMATION RESOURCES.pptxDRUG INFORMATION RESOURCES.pptx
DRUG INFORMATION RESOURCES.pptxPunamGauchan1
 
Pharmacokinetic Drug-Drug interactions
Pharmacokinetic Drug-Drug interactionsPharmacokinetic Drug-Drug interactions
Pharmacokinetic Drug-Drug interactionsAreej Abu Hanieh
 
Drug information center in a retail Drug Store
Drug information center in a retail Drug StoreDrug information center in a retail Drug Store
Drug information center in a retail Drug StoreYamini Shah
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenpavithra vinayak
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismDr. Ankit Gaur
 
Rational drug use and essential drugs
Rational drug use and essential drugsRational drug use and essential drugs
Rational drug use and essential drugsKoppala RVS Chaitanya
 
Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics Areej Abu Hanieh
 
Effect of liver disease on pharmacokinetics
 Effect of liver disease on pharmacokinetics  Effect of liver disease on pharmacokinetics
Effect of liver disease on pharmacokinetics pavithra vinayak
 
dosage adjustment in renal and hepatic failure for medical student
dosage adjustment in renal and hepatic failure for medical studentdosage adjustment in renal and hepatic failure for medical student
dosage adjustment in renal and hepatic failure for medical studentDeepaJoshi41
 
Dose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failurePallavi Kurra
 
Hospital pharmacy management
Hospital pharmacy managementHospital pharmacy management
Hospital pharmacy managementArmin Eisazaei
 
ADR MONITORING IN COMMUNITY PHARMACY.pdf
ADR MONITORING IN COMMUNITY PHARMACY.pdfADR MONITORING IN COMMUNITY PHARMACY.pdf
ADR MONITORING IN COMMUNITY PHARMACY.pdfAmeena Kadar
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxAmeena Kadar
 

What's hot (20)

Geriatrics
GeriatricsGeriatrics
Geriatrics
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
DRUG INFORMATION RESOURCES.pptx
DRUG INFORMATION RESOURCES.pptxDRUG INFORMATION RESOURCES.pptx
DRUG INFORMATION RESOURCES.pptx
 
Pharmacokinetic Drug-Drug interactions
Pharmacokinetic Drug-Drug interactionsPharmacokinetic Drug-Drug interactions
Pharmacokinetic Drug-Drug interactions
 
Drug information center in a retail Drug Store
Drug information center in a retail Drug StoreDrug information center in a retail Drug Store
Drug information center in a retail Drug Store
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
 
Polypharmacy and medication errors
Polypharmacy and medication errorsPolypharmacy and medication errors
Polypharmacy and medication errors
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolism
 
pharmacovigilance.pptx
pharmacovigilance.pptxpharmacovigilance.pptx
pharmacovigilance.pptx
 
Rational drug use and essential drugs
Rational drug use and essential drugsRational drug use and essential drugs
Rational drug use and essential drugs
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
 
Effect of liver disease on pharmacokinetics
 Effect of liver disease on pharmacokinetics  Effect of liver disease on pharmacokinetics
Effect of liver disease on pharmacokinetics
 
dosage adjustment in renal and hepatic failure for medical student
dosage adjustment in renal and hepatic failure for medical studentdosage adjustment in renal and hepatic failure for medical student
dosage adjustment in renal and hepatic failure for medical student
 
Dose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failure
 
Hospital pharmacy management
Hospital pharmacy managementHospital pharmacy management
Hospital pharmacy management
 
ADR MONITORING IN COMMUNITY PHARMACY.pdf
ADR MONITORING IN COMMUNITY PHARMACY.pdfADR MONITORING IN COMMUNITY PHARMACY.pdf
ADR MONITORING IN COMMUNITY PHARMACY.pdf
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptx
 

Similar to Drug used in geriartics

Pharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsPharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsSafaa Ali
 
Use of drugs in geriatric patients
Use of drugs in geriatric patientsUse of drugs in geriatric patients
Use of drugs in geriatric patientsDr. Yash Panchal
 
Factors modifying drug effects
Factors modifying drug effectsFactors modifying drug effects
Factors modifying drug effectsAbhinav Sawhney
 
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...Abhinav S
 
Medication use in elderly
Medication use in elderlyMedication use in elderly
Medication use in elderlyDoha Rasheedy
 
QUM in Geriatric Patients.pptx
QUM in Geriatric Patients.pptxQUM in Geriatric Patients.pptx
QUM in Geriatric Patients.pptxSaniya Shaikh
 
geriatric kinetic ADME pharmacokinetic.pptx
geriatric kinetic ADME pharmacokinetic.pptxgeriatric kinetic ADME pharmacokinetic.pptx
geriatric kinetic ADME pharmacokinetic.pptxSubohNada
 
Prescribing in physiological and pathological conditions
Prescribing in physiological and pathological conditionsPrescribing in physiological and pathological conditions
Prescribing in physiological and pathological conditionsDrSahilKumar
 
Factors modifying dose and action of drugs
Factors modifying dose and action of drugsFactors modifying dose and action of drugs
Factors modifying dose and action of drugsAnisha Pamarthi
 
Prescribing in physiological conditions
Prescribing in physiological conditionsPrescribing in physiological conditions
Prescribing in physiological conditionsDr. Siddhartha Dutta
 
Geriatrics pharmacology
Geriatrics pharmacologyGeriatrics pharmacology
Geriatrics pharmacologySaba Ahmed
 
P'kinetics &; drug therapy
P'kinetics  &; drug therapyP'kinetics  &; drug therapy
P'kinetics &; drug therapyHeena Parveen
 

Similar to Drug used in geriartics (20)

Geriatrics
GeriatricsGeriatrics
Geriatrics
 
Pharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsPharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adults
 
Use of drugs in geriatric patients
Use of drugs in geriatric patientsUse of drugs in geriatric patients
Use of drugs in geriatric patients
 
Geriatrics
GeriatricsGeriatrics
Geriatrics
 
Factors modifying drug effects
Factors modifying drug effectsFactors modifying drug effects
Factors modifying drug effects
 
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...
 
Medication use in elderly
Medication use in elderlyMedication use in elderly
Medication use in elderly
 
Case study.
Case study.Case study.
Case study.
 
QUM in Geriatric Patients.pptx
QUM in Geriatric Patients.pptxQUM in Geriatric Patients.pptx
QUM in Geriatric Patients.pptx
 
geriatric kinetic ADME pharmacokinetic.pptx
geriatric kinetic ADME pharmacokinetic.pptxgeriatric kinetic ADME pharmacokinetic.pptx
geriatric kinetic ADME pharmacokinetic.pptx
 
Prescribing in physiological and pathological conditions
Prescribing in physiological and pathological conditionsPrescribing in physiological and pathological conditions
Prescribing in physiological and pathological conditions
 
Factors modifying dose and action of drugs
Factors modifying dose and action of drugsFactors modifying dose and action of drugs
Factors modifying dose and action of drugs
 
Prescribing in physiological conditions
Prescribing in physiological conditionsPrescribing in physiological conditions
Prescribing in physiological conditions
 
drugs.pptx
drugs.pptxdrugs.pptx
drugs.pptx
 
Aditya gaederatric
Aditya gaederatricAditya gaederatric
Aditya gaederatric
 
Geriatrics pharmacology
Geriatrics pharmacologyGeriatrics pharmacology
Geriatrics pharmacology
 
Geriatric pharmacology
Geriatric pharmacologyGeriatric pharmacology
Geriatric pharmacology
 
P'kinetics &; drug therapy
P'kinetics  &; drug therapyP'kinetics  &; drug therapy
P'kinetics &; drug therapy
 
antihypertensive_agents.pdf
antihypertensive_agents.pdfantihypertensive_agents.pdf
antihypertensive_agents.pdf
 
Drug metabolism affected by diseases
Drug metabolism affected by diseasesDrug metabolism affected by diseases
Drug metabolism affected by diseases
 

Recently uploaded

Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationSafe Software
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptxLBM Solutions
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationSlibray Presentation
 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024Lorenzo Miniero
 
"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr BaganFwdays
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupFlorian Wilhelm
 
SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024Scott Keck-Warren
 
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024BookNet Canada
 
Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Scott Keck-Warren
 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticscarlostorres15106
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Mark Simos
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii SoldatenkoFwdays
 
Understanding the Laravel MVC Architecture
Understanding the Laravel MVC ArchitectureUnderstanding the Laravel MVC Architecture
Understanding the Laravel MVC ArchitecturePixlogix Infotech
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubKalema Edgar
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsMemoori
 
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...Patryk Bandurski
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsMiki Katsuragi
 
Pigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping ElbowsPigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping ElbowsPigging Solutions
 

Recently uploaded (20)

DMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special EditionDMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special Edition
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptx
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck Presentation
 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024
 
"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project Setup
 
SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024
 
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
 
Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024
 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko
 
Understanding the Laravel MVC Architecture
Understanding the Laravel MVC ArchitectureUnderstanding the Laravel MVC Architecture
Understanding the Laravel MVC Architecture
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding Club
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial Buildings
 
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering Tips
 
Pigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping ElbowsPigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping Elbows
 
Vulnerability_Management_GRC_by Sohang Sengupta.pptx
Vulnerability_Management_GRC_by Sohang Sengupta.pptxVulnerability_Management_GRC_by Sohang Sengupta.pptx
Vulnerability_Management_GRC_by Sohang Sengupta.pptx
 

Drug used in geriartics

  • 1. DRUG USED IN GERIATRICS BY VRUSHALI NEVE Asst. professor Pharmacology dept.
  • 2. Introduction 1.Geriatrics refers to physical, pathological aspects of elderly 2.The elderly have multiple and often chronic diseases. 3.It is not surprising tharefore that they are major consumer of drugs. 4.Common diseases in geriatrics are: A. Hypertension B. Dibaties mellitus C. Arthritis D. Hearing loss E. Parkinsonims disease F. Alzheimer disease
  • 3. PRINCIPLE UNDERLYING FACTORS • Altered Pharmacokinetics • Altered Pharmacodynamic • Multiple drug therapy • Poor compliance
  • 4. Pharmacokinetic changes in geriatrics Ageing result in many physiological changes that could affect absorption, first pass metabolism ,distribution ,protein binding and elimination of drugs Age related changes in GI tract ,liver and kidney are: 1.Reduce gastric acid secretion 2.Decresed GI motility 3.Reduced total surface of absorption 4.Reduced splanchnic blood flow 5.Reduced liver size 6.Reduced liver blood flow 7.Reduced glomerular filtration 8.Reduced renal tubular filtration
  • 5. 1. Absorption: There is delay in gastric emptying, reduction in gastric acid output with aging. Absorption of some drug like digoxin may be slower . 2. First pass metabolism: a .After absorption drug are transported via portal circulation to liver where many lipid soluble drugs are metabolized extensively. b. This result in marked reduction in systemic bioavailability. c. Minor reduction in first pass metabolism can result in significance increase in bioavailability of such drugs. 3. Distribution: Age related physiological change which may affect drug distribution are : 1. reduced lean body mass 2.Reduced total body water 3. Increased total body fat 4. Lower serum albumin level
  • 6.  Increased body fat in eldrly result in increased volume of distribution for fat soluble compound such as clomethiazole ,diazepam.  Reduction in body water result in reduced volume of distribution of water soluble drugs like cimetidine, digoxin, alcohol  Plasma albumin level decreases with age therefore free fraction of acidic drugs like cimetidine, furosemide will increases
  • 7. 4. Renal clearance: There will be variability in renal function in elderly , in general glomerular filtration rate decline which affect renal plasma flow and renal tubular function. Because of marked variability in renal function in elderly dosage of predominantly renaly excreted drug should be indiviuialized. 5.Hepatic clearance, ClH: It is depend on hepatic blood flow Q, and steady state extraction ratio E, as seen in formula : Cl H = Q × Ca- Cv/Ca where Ca and Cv are arterial and venous concentrations of drug
  • 8. Pharmacodynamics 1.Age related changes in specific receptors and target sites: 1.α adrenoreceptors: It appears to reduced with ageing while α1 adrenoreceptor responsivness is unaffected 2.β adrenoreceptors: Its function is decline with age. It is recognise that chronotropic response to isoprenaline infusion is less marked in elderly
  • 9. 2.Reduction in homeostasis: 1. Orthostatic circulatory response: Structural changes in vascular tree that occur with ageing . Antihypertensive drug with α receptor blocking effect, antiparkinson drugs more likely to produce hypotension in elderly 2.Thermoregulation: Increases of thermoregulatory mechanism in elderly .Ex. Benzodiazepines, opioids, alcohol. 3. Congitive function :Aging is associated with marked structural and neurochemical changes in CNS
  • 10. Drugs that need to be used with caution in elderly DRUGS SIGNIFICANT ADR SPECIAL CONSIDERATION NSAID GI, Ulceration, bleeding renal impairment First try Paracetamol, monitor renal function Antibiotic- Cotrimazole Serious hypersensitivity reaction Trimethoprime is equally safe, effective for UTI Sulfonylureas (long acting) Increase risk of hypoglycemia Shorter acting agents are preferred Colchicine Diarrhoea ,dehydration Not recommended for chronic therapy
  • 11. Principle and goals of drug therapy 1. Unnecessary use of hypnotics should be avoided in mild hypertension 2. Aim of treatment is not just to prolong life but also to improve quality of life 3. Drug history will help to avoid potentially serious drug interaction 4. Dose titration will help to know age related alteration that may effect drug response 5. Packaging and labeling: Many elderly patients with arthritis find it difficult to open container
  • 12. Care to be taken  Select drugs reported to be safe  Avoid unsafe drugs  Prepare dose and dosing schedule  Record drug history carefully before prescription  Try to reduce use of number of drugs